I’m sympathetic to the dilemma of the Child Psychiatrists and parents when they are presented with the a chronically out-of-control kid. I have seen some myself and they are diagnostic and management problems of the first order, particularly in an era where there’s no inpatient back-up for evaluation. We’ve all have heard the debate about […]
We hold these truths to be self-evident, that all men are created equal, that they are endowed by their Creator with certain unalienable Rights, that among these are Life, Liberty and the pursuit of Happiness. A well regulated militia, being necessary to the security of a free state, the right of the people to keep […]
One Last Chance for the APA to Make the DSM-5 Safer Huffington Post by Allen Frances 12/17/2012 Two weeks ago the Trustees of the American Psychiatric Association made the serious mistake of approving and rushing to press a DSM-5 that has many unsafe and untested suggestions. The reaction has been unexpectedly heated: dozens of extremely […]
Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. by McGorry PD, Nelson B, Phillips LJ, Yuen HP, Francey SM, Thampi A, Berger GE, Amminger GP, Simmons MB, Kelly D, Thompson AD, and Yung AR. Journal of Clinical Psychiatry. 2012 Nov 27. [Epub ahead of print] OBJECTIVE: The ultra-high […]
Supreme Court takes up case on generic drugs Politico By BRETT NORMAN 12/10/12 The Supreme Court will take up “pay for delay” — the multibillion-dollar dispute over whether brand-name drug makers should be able to pay generic drug companies for agreeing to delay putting cheaper versions on the market. The justices agreed Friday to hear […]
Harry Stack Sullivan was an American Psychiatrist in the first half of the 20th Century. His Interpersonal Psychiatry wove in and out of the psychoanalytic movement of the time, but there were substantive differences now little discussed in this era of pharmacology. One of those differences had to do with Freud’s concept of the unconscious. […]
A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites by Dunlop BW, Thase ME, Wun CC, Fayyad R, Guico-Pabia CJ, Musgnung J, and Ninan PT. Neuropsychopharmacology. 2012 37[13]:2830-2836. Variability in placebo response greatly complicates the design, conduct, and interpretation of clinical trials of antidepressant medications. To identify […]
While there’s reason to be encouraged that awareness of the invasion of Medicine by the Pharmaceutical Industry is increasing and, at least in Psychiatry, PHARMA is moving away from flooding the market with CNS Drugs, there remain huge forces supporting the inappropriate medication waves that have played havoc with the rational practice of Medicine. One […]
National Trends in the Office-Based Treatment of Children, Adolescents, and Adults With Antipsychotics by Mark Olfson, MD, MPH; Carlos Blanco, MD, PhD; Shang-Min Liu, MS; Shuai Wang, PhD; and Christoph U. Correll, MD Archives of General Psychiatry. 2012 69[12]:1247-1256. Context: Although antipsychotic treatment has recently increased, little is known about how this development has differentially […]